Option Care Health, Inc. (OPCH) Balance Sheet

The steady increase in leverage, despite stable total debt around $1.2-1.3B, is driven by a slight contraction in equity from $1.4B to $1.3B. This suggests that retained earnings growth is being offset by share repurchases or other equity reductions. The declining cash balance, from a peak of $483.0M in 2024Q3 to $193.8M in 2026Q2, may indicate increased cash deployment into operations or acquisitions, but it also reduces the liquidity buffer.

The stability in absolute debt levels indicates that OPCH is not aggressively taking on new debt, but the rising D/E ratio reflects a shrinking equity base. This could be due to share buybacks, which totaled $153.0M in 2026Q2 per cash flow data, reducing equity. The debt-to-assets ratio also increased from 0.36 to 0.38, implying a slightly higher reliance on debt financing. Given the company's low-margin, high-volume model, this leverage level appears manageable but warrants monitoring if interest rates remain elevated.

The substantial goodwill, likely from the BioScrip merger, exposes OPCH to impairment risk if growth expectations are not met. The sharp decline in PPE from Q1 to Q2 2026 is unusual and may reflect a reclassification or disposal of assets, though the reason is not disclosed. The asset mix is heavily weighted toward intangibles, which is typical for a service company but raises questions about the quality of the asset base if cash flows deteriorate.

The doubling of retained earnings over ten quarters demonstrates strong profitability, but the stagnant equity suggests that management is returning capital to shareholders via buybacks. This is consistent with the cash flow statement showing $153.0M in buybacks in 2026Q2. While buybacks can enhance EPS, they also increase financial leverage and reduce the equity cushion. Investors should monitor whether this capital allocation strategy is sustainable given the rising D/E ratio.

The declining current ratio indicates that current liabilities are growing faster than current assets, which could be due to increased payables or accrued expenses. The cash balance, though still positive, is at its lowest level in the past ten quarters, except for 2025Q1. Given the company's low operating margins, a thinner cash buffer may increase vulnerability to working capital swings, which have been volatile as seen in the cash flow analysis.